Filing Details

Accession Number:
0001013762-23-003901
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-13 18:56:56
Reporting Period:
2023-10-13
Accepted Time:
2023-10-13 18:56:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1788028 Jasper Therapeutics Inc. JSPR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1574558 William Lis C/O Jasper Therapeutics, Inc.
2200 Bridge Pkwy, Suite #102
Redwood City CA 94065
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Disposition 2023-10-13 7,965 $0.85 53,521 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted by the Reporting Person on June 15, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.84 to $0.8717, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.